LILY34:BVMF
Eli Lilly And Company BDR
R$२६८.६०
arrow_downward
-१.१०%(-३.००) १ दि
१९ नोव्हें, ६:०६:०० PM [GMT]-३ · BRL
search
सर्व सिम्बॉल
| सिम्बॉल | किंमत | बदल | % बदल |
|---|
insights_autoLILY34 साठी टॉप इनसाइट जनरेट करत आहे...
उघडा
R$२६८.५८
उच्च
R$२७१.७६
कमी
R$२६३.९२
मार्केट कॅप
१२.७१ खर्व
सरासरी उलाढाल
४९.५९ ह
उलाढाल
०.००
५२ आठवड्यांतील उच्चांक
R$२८१.७५
५२ आठवड्यांतील नीचांक
R$१४१.५९
थकित शेअर
९४.०७ कोटी
कर्मचाऱ्यांची संख्या
५० ह
उघडा
R$२६८.५८
उच्च
R$२७१.७६
कमी
R$२६३.९२
मार्केट कॅप
१२.७१ खर्व
सरासरी उलाढाल
४९.५९ ह
उलाढाल
०.००
५२ आठवड्यांतील उच्चांक
R$२८१.७५
५२ आठवड्यांतील नीचांक
R$१४१.५९
थकित शेअर
९४.०७ कोटी
कर्मचाऱ्यांची संख्या
५० ह
बातम्यांच्या स्टोरी
वेब स्रोत आणि बातमी भागीदारांकडून
The Business Journals
·
८ तासांपूर्वी
Federal judge dismisses Tampa General Hospital's lawsuit against Eli Lilly
Yahoo Finance
·
११ तासांपूर्वी
Eli Lilly (LLY) – The Only Healthcare Name in Ken Fisher’s Fastest-Growing Top Positions
24/7 Wall St.
·
११ तासांपूर्वी
$1,000 Invested in Eli Lilly 10 Years Ago Would Be Worth a Fortune Today
The Globe and Mail
·
१३ तासांपूर्वी
Is Immunology Emerging as Eli Lilly's Next Growth Driver?
प्रोफाइल
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Eli Lilly And Company BDR बद्दल
CEOडेव्हिड ए. रिक्स
कर्मचारी५० ह
स्थापना१८७६
मुख्यालयेइनडियनॅपलिस, इंडियाना, संयुक्त राष्ट्र
क्षेत्रHealth Care
उद्योग-
वेबसाइटlilly.com